CasLoc logo
All Cases PTAB Litigations UPC Oppositions

SYMED LABS LIMITED v. GLENMARK PHARMACEUTICALS INC., USA

2:15-cv-08306

Overview

Case Number 2:15-cv-08306
Filing Date 2015-11-25
Status Terminated
Termination Date 2018-12-07
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

GLENMARK PHARMACEUTICALS INC., USA Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

SYMED LABS LIMITED NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7732597
Crystalline form of linezolid
Filed: 2007-09-26
Issued: 2010-06-08
Expired (Term Ended)
Expires: 2024-02-22

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

10

Dispositive

0

Granted

4

Denied

0

Pending / Review

3

Motions by Category

Procedural / Extension Motion 9 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Procedural / Extension Motion Granted in Part
ORDER that Plaintiffs 202 motion in 15-8304 to amend the Complaints is GRANTED IN PART AND DENIED IN PART; Plaintiffs motion to amend infringement ontentions is...
Entry #53 • 2018-11-02 Document →
Procedural / Extension Motion Granted
ORDER granting 45 Motion for Leave to Appear Pro Hac Vice as to JANET LINN, ESQ. Signed by Magistrate Judge Mark Falk on 11/1/17. (DD, ) (Entered: 11/02/2017)
Entry #46 • 2017-11-02 Document →
Procedural / Extension Motion Pending
Set/Reset Deadlines as to 45 MOTION for Leave to Appear Pro Hac Vice Janet Linn, Esq.. Motion set for 12/4/2017 before Judge Claire C. Cecchi. Unless otherwise ...
Entry #β€” • 2017-11-01
Procedural / Extension Motion Granted
MOTION for Leave to Appear Pro Hac Vice Janet Linn, Esq. by All Plaintiffs. (Attachments: # 1 Text of Proposed Order, # 2 Certification C. Saveriano, # 3 Certif...
Entry #45 • 2017-10-31 Document →
Claim Construction / Markman Filing Pending / Under Review
TEXT ORDER - A Markman Hearing is scheduled for OCTOBER 3, 2017 at 10:00 a.m. before Judge Claire C. Cecchi. SO ORDERED by Judge Claire C. Cecchi on 8/10/17. (j...
Entry #42 • 2017-08-10 Document →
Procedural / Extension Motion Granted
ORDER granting 33 Motion for Leave to Appear Pro Hac Vice as to MARK S. GRAHAM, ESQ. Signed by Magistrate Judge Mark Falk on 3/10/16. (DD, ) (Entered: 03/10/201...
Entry #34 • 2016-03-10 Document →

Docket Entries

(75 total)
Pleading / Complaint

COMPLAINT against GLENMARK PHARMACEUTICALS INC., USA ( Filing and Admin fee $ 400 receipt number 0312-6781253) with JURY DEMAND, filed by SYMED LABS LIMITED, HETERO USA, INC.. (Attachments: # 1 Exhibit a, # 2 Exhibit b, # 3 Certification, # 4 Civil Cover Sheet)(mfg, ) (Entered: 11/30/2015)

Entry #1 • 2015-11-25
1
Pleading / Complaint

COMPLAINT against GLENMARK PHARMACEUTICALS INC., USA ( Filing and Admin fee $ 400 receipt number 0312-6781253) with JURY DEMAND, filed by SYMED LABS LIMITED, HETERO USA, INC.. (Attachments: # 1 Exhibit a, # 2 Exhibit b, # 3 Certification, # 4 Civil Cover Sheet)(mfg, ) (Entered: 11/30/2015)

Entry #1 • 2015-11-25
2
Pleading / Complaint

COMPLAINT against GLENMARK PHARMACEUTICALS INC., USA ( Filing and Admin fee $ 400 receipt number 0312-6781253) with JURY DEMAND, filed by SYMED LABS LIMITED, HETERO USA, INC.. (Attachments: # 1 Exhibit a, # 2 Exhibit b, # 3 Certification, # 4 Civil Cover Sheet)(mfg, ) (Entered: 11/30/2015)

Entry #1 • 2015-11-25
2
Pleading / Complaint

COMPLAINT against GLENMARK PHARMACEUTICALS INC., USA ( Filing and Admin fee $ 400 receipt number 0312-6781253) with JURY DEMAND, filed by SYMED LABS LIMITED, HETERO USA, INC.. (Attachments: # 1 Exhibit a, # 2 Exhibit b, # 3 Certification, # 4 Civil Cover Sheet)(mfg, ) (Entered: 11/30/2015)

Entry #1 • 2015-11-25
2
Pleading / Complaint

COMPLAINT against GLENMARK PHARMACEUTICALS INC., USA ( Filing and Admin fee $ 400 receipt number 0312-6781253) with JURY DEMAND, filed by SYMED LABS LIMITED, HETERO USA, INC.. (Attachments: # 1 Exhibit a, # 2 Exhibit b, # 3 Certification, # 4 Civil Cover Sheet)(mfg, ) (Entered: 11/30/2015)

Entry #1 • 2015-11-25
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc